The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
Abstract The SARS-CoV-2 virus has spread world-wide since December 2019, killing more than 2.9 million of people. We have adapted a statistical model from the SIR epidemiological models to predict the spread of SARS-CoV-2 in France. Our model is based on several parameters and assumed a 4.2% seropre...
Guardado en:
Autores principales: | Chloé Dimeglio, Jean-Michel Loubes, Marcel Miedougé, Fabrice Herin, Jean-Marc Soulat, Jacques Izopet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c8e3153d844405baaa3d65b65d428d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Ann-Sofie Rudberg, et al.
Publicado: (2020) -
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Dianna L. Ng, et al.
Publicado: (2020) -
High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden
por: Johanna F. Lindahl, et al.
Publicado: (2020) -
SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Hiroshi Fukuda, et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka
por: Chandima Jeewandara, et al.
Publicado: (2021)